Thrombin induces expression of cytokine-induced SH2 protein (CIS) in rat brain astrocytes: Involvement of phospholipase A2, cyclooxygenase, and lipoxygenase

GLIA

Volumn 48, Issue 2, 2004, Pages 102-111

  Ji, Kyung Ae ^a   Yang, Myung Soon ^a   Jou, Ilo ^a   Shong, Min Ho ^b   Joe, Eun Hye ^a,c  

^a Ajou University School of Medicine   (South Korea)

^b Chungnam National University   (South Korea)

^c NONE   (South Korea)

Author keywords

Inflammation; Neuroimmunology; Signal transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; CYTOKINE INDUCED SH2 PROTEIN; ENZYME INHIBITOR; GAMMA INTERFERON; JANUS KINASE 2; JANUS KINASE 3; LEUKOTRIENE B4; LIPOXYGENASE; LUCIFERASE; MESSENGER RNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROTEIN SH2; REACTIVE OXYGEN METABOLITE; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; THROMBIN; TROLOX C; UNCLASSIFIED DRUG; WHI P 154; WHI P 97;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CONTROLLED STUDY; GENETIC TRANSFECTION; INFLAMMATION; NEGATIVE FEEDBACK; NEUROIMMUNOLOGY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELLS, CULTURED; DINOPROSTONE; DNA-BINDING PROTEINS; ENCEPHALITIS; ENZYME INHIBITORS; FEEDBACK, BIOCHEMICAL; FREE RADICAL SCAVENGERS; IMMEDIATE-EARLY PROTEINS; INFLAMMATION MEDIATORS; INTERFERON TYPE II; LEUKOTRIENE B4; LIPOXYGENASE; PHOSPHOLIPASES A; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; THROMBIN; TRANS-ACTIVATORS; UP-REGULATION;

EID: 9144251168     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20059     Document Type: Article

References (39)

1. Banks WA, Kastin AJ. 1983. Aluminium increases permeability of the blood-brain barrier to labelled DSIP and beta-endorphin: possible implications for senile and dialysis dementia. Lancet 2:1227-1229.
2. Bizios R, Lai L, Fenton JW, Malik AB. 1986. Thrombin-induced chemotaxis and aggregation of neutrophils. J Cell Physiol 128:485-490.
3. Bousquet C, Chesnokova V, Kariagina A, Ferrand A, Melmed S. 2001. cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action. Mol Endocrinol 15:1880-1890.
4. Chen XP, Losman JA, Rothman P. 2000. SOCS proteins, regulators of intracellular signaling. Immunity 13:287-290.
5. Cwikel S, Silvian-Drachsler I, Prolov L, Hooghe-Peters EL, Merchav S. 2001. Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitors. Exp Hematol 29:937-942.
6. Dalpke AH, Opper S, Zimmermann S, Heeg K. 2001. Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. J Immunol 166:7082-7089.
7. Darnell JE Jr, Kerr IM, Stark GR. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
8. Dong Y, Benveniste EN. 2001. Immune function of astrocytes. Glia 36:180-190.
9. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921-924.
10. Federici M, Giustizieri ML, Scarponi C, Girolomoni G, Albanesi C. 2002. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1. J Immunol 169:434-442.
11. Freeman BA, Crapo JD. 1982. Biology of disease: free radicals and tissue injury. Lab Invest 47:412-426.
12. Giulian D, Baker TJ. 1986. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 6:2163-2178.
13. Holland JA, Meyer JW, Chang MM, O'Donnell RW, Johnson DK, Ziegler LM. 1998. Thrombin stimulated reactive oxygen species production in cultured human endothelial cells. Endothelium 6:113-121.
14. Huang D, Han Y, Rani MR, Glabinski A, Trebst C, Sorensen T, Tani M, Wang J, Chien P, O'Bryan S, Bielecki B, Zhou ZL, Majumder S, Ransohoff RM. 2000. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol Rev 177:52-67.
15. Jones A, Geczy CL. 1990. Thrombin and factor Xa enhance the production of interleukin-1. Immunology 71:236-241.
16. Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW. 2002. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285:1-24.
17. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW. 1993. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol 150: 2659-2667.
18. Li Y, Ferrante A, Poulos A, Harvey DP. 1996. Neutrophil oxygen radical generation. Synergistic responses to tumor necrosis factor and mono/polyunsaturated fatty acids. J Clin Invest 97:1605-1609.
19. Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H, Miyajima A, Yoshimura A. 1997. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STATS activation. Blood 89:3148-3154.
20. Matsumoto A, Seki Y, Kubo M, Ohtsuka S, Suzuki A, Hayashi I, Tsuji K, Nakahata T, Okabe M, Yamada S, Yoshimura A. 1999. Suppression of STATS functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice. Mol Cell Biol 19:6396-6407.
21. Meli R, Raso GM, Cicala C, Esposito E, Fiorino F, Cirino G. 2001. Thrombin and PAR-1 activating peptide increase iNOS expression in cytokine-stimulated C6 glioma cells. J Neurochem 79:556-563.
22. Mrak RE, Griffin WS. 2001. Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol Aging 22:903-908.
23. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924-929.
24. Naldini A, Sower L, Bocci V, Meyers B, Carney DH. 1998. Thrombin receptor expression and responsiveness of human monocytic cells to thrombin is linked to interferon-induced cellular differentiation. J Cell Physiol 177:76-84.
25. Nishino A, Suzuki M, Ohtani H, Motohashi O, Umezawa K, Nagura H, Yoshimoto T. 1993. Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 10:167-179.
26. Okabe S, Tauchi T, Morita H, Ohashi H, Yoshimura A, Ohyashiki K. 1999. Thrombopoietin induces an SH2-containing protein, CIS1, which binds to Mp1: involvement of the ubiquitin proteosome pathway. Exp Hematol 27:1542-1547.
27. Olsson Y, Brun A, Englund E. 1996. Fundamental pathological lesions in vascular dementia. Acta Neurol Scand 168(suppl):31-38.
28. Ridet JL, Malhotra SK, Privat A, Gage FH. 1997. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20:570-577.
29. Ryu J, Pyo H, Jou I, Joe E. 2000. Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogen-activated protein kinase, and NF-kappa B. J Biol Chem 275:29955-29959.
30. Sakamoto H, Yasukawa H, Masuhara M, Tanimura S, Sasaki A, Yuge K, Ohtsubo M, Ohtsuka A, Fujita T, Ohta T, Furukawa Y, Iwase S, Yamada H, Yoshimura A. 1998. A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons. Blood 92:1668-1676.
31. Sasaki A, Yasukawa H, Suzuki A, Kamizono S, Syoda T, Kinjyo I, Sasaki M, Johnston JA, Yoshimura A. 1999. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 4:339-351.
32. + exchange by a thrombin receptor antagonist. Biochem Pharmacol 49:519-528.
33. Sekharam M, Cunnick JM, Wu J. 2000. Involvement of lipoxygenase in lysophosphatidic acid-stimulated hydrogen peroxide release in human HaCaT keratinocytes. Biochem J 346 Pt 3:751-758.
34. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387: 917-921.
35. Suzuki A, Kanada T, Mitsuyama K, Yoshida T, Kamizono S, Hoshino T, Kubo M, Yamashita A, Okabe M, Takeda K, Akira S, Matsumoto S, Toyonaga A, Sata M, Yoshimura A. 2001. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med 193:471-481.
36. Verdier F, Chretien S, Muller O, Varlet P, Yoshimura A, Gisselbrecht S, Lacombe C, Mayeux P. 1998. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STATS) activation. Possible involvement of the ubiquitinated Cis protein. J Biol Chem 273:28185-28190.
37. Viviani B, Corsini E, Pesenti M, Galli CL, Marinovich M. 2001. Trimethyltin-activated cyclooxygenase stimulates tumor necrosis factor-alpha release from glial cells through reactive oxygen species. Toxicol Appl Pharmacol 172:93-97.
38. Yasukawa H, Sasaki A, Yoshimura A. 2000. Negative regulation of cytokine signaling pathways. Annu Rev Immunol 18:143-164.
39. Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Kara T, Miyajima A. 1995. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J 14:2816-2826.